PHARM CJSC CLOSED JOINT STOCK COMPANY R has a total of 14 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Philippines and Singapore. Its main competitors in its focus markets pharmaceuticals and biotechnology are HUMAN GENOME SCIENCES, CENTOCOR INC and ALLERGENE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Philippines | 2 | |
#3 | Singapore | 2 | |
#4 | Canada | 1 | |
#5 | Chile | 1 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Ignatiev Vasily | 12 |
#2 | Repik Alexey | 12 |
#3 | Samsonov Mikhail | 12 |
#4 | Xu Ting | 11 |
#5 | Lavrovsky Yan | 11 |
#6 | Xu Tao | 6 |
#7 | Guo Kangping | 4 |
#8 | Vasily Ignatiev | 2 |
#9 | Mikhail Samsonov | 2 |
#10 | Ting Xu | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014126582A1 | IL-1β INHIBITOR COMPOSITION AND USE THEREOF | |
WO2014107165A1 | Fully human antibodies against human receptor igf-1r | |
WO2014035361A1 | IL-1β INHIBITOR COMPOSITION AND USE THEREOF | |
SG11201406216XA | Osteoprotegerin derived composition and use thereof |